RC3H1 and neoplasm: To summarize, in our view the engineering of CAR macrophages derived from iPSCs, utilizing CRISPR-Cas9 to knockout Roquin-1 and Regnase-1, presents a viable approach to overcome the immunosuppressive tumour microenvironment.